Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis

被引:23
作者
Kamarajah, Sivesh K. [1 ]
机构
[1] Univ Birmingham, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England
关键词
resection; liver; HCC; outcomes; fibrosis; CLINICAL-PRACTICE GUIDELINES; LIVER-TRANSPLANTATION; SURGICAL RESECTION; HEPATIC RESECTION; ANTIVIRAL THERAPY; MILAN CRITERIA; MANAGEMENT; HEPATECTOMY; VALIDATION; PROGNOSIS;
D O I
10.1016/j.asjsur.2018.01.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background/Objectives: Surgical extirpation for hepatocellular carcinoma (HCC) with background fibrosis remains a challenge. This study evaluated impact of fibrosis score on long term outcomes of patients undergoing surgical resection for HCC. Methods: Using the Surveillance, Epidemiology and End Results (SEER) database (2004-2013), complete data on 1433 patients undergoing surgical resection for non-metastatic HCC were identified. Overall survival (OS) was estimated using the Kaplan-Meier method. Cox proportional hazards model were used to produce adjusted hazard ratios (HR). Results: In this study, 54% (650/1433) patients had F5-6 fibrosis at the time for surgical resection of HCC. In adjusted models, F5/6 fibrosis significantly reduces overall survival (HR: 1.62, 95% CI: 1.34-1.94; p < 0.001). Median survival was significantly longer for patients with F0-4 fibrosis for T1a, T1b and T2 tumours as compared to F5-6 fibrosis, not for T3 and T4 tumours, even when stratified by extent of hepatectomy. There were no significant differences in 90-day post-operative mortality between fibrosis groups when stratified by T-classifications. Conclusion: Liver resection in patients with advanced fibrosis has significantly lower survival as compared to patients with F0-4 fibrosis in early stage (T1 and T2), not advanced tumours (T3 and T4). Improvement in patient selection and perioperative care for liver resection may offer consistent and clinically meaningful long-term survival in HCC. (C) 2018 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.
引用
收藏
页码:551 / 561
页数:11
相关论文
共 37 条
[21]   Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update [J].
Omata, Masao ;
Cheng, Ann-Lii ;
Kokudo, Norihiro ;
Kudo, Masatoshi ;
Lee, Jeong Min ;
Jia, Jidong ;
Tateishi, Ryosuke ;
Han, Kwang-Hyub ;
Chawla, Yoghesh K. ;
Shiina, Shuichiro ;
Jafri, Wasim ;
Alcantara Payawal, Diana ;
Ohki, Takamasa ;
Ogasawara, Sadahisa ;
Chen, Pei-Jer ;
Lesmana, Cosmas Rinaldi A. ;
Lesmana, Laurentius A. ;
Gani, Rino A. ;
Obi, Shuntaro ;
Dokmeci, A. Kadir ;
Sarin, Shiv Kumar .
HEPATOLOGY INTERNATIONAL, 2017, 11 (04) :317-370
[22]   Hepatic Resection for Hepatocellular Carcinoma Meeting Milan Criteria in Child-Turcotte-Pugh Class A Patients With Cirrhosis [J].
Park, Y. -K. ;
Kim, B. -W. ;
Wang, H. -J. ;
Kim, M. -W. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (05) :1691-1697
[23]   Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter study [J].
Pawlik, TM ;
Poon, RT ;
Abdalla, EK ;
Ikai, I ;
Nagorney, DM ;
Belghiti, M ;
Kianmanesh, R ;
Ng, IOL ;
Curley, SA ;
Yamaoka, Y ;
Lauwers, GY ;
Vauthey, JN .
SURGERY, 2005, 137 (04) :403-410
[24]   Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma [J].
Pawlik, TM ;
Poon, RT ;
Abdalla, EK ;
Zorzi, D ;
Ikai, I ;
Curley, SA ;
Nagorney, DM ;
Belghiti, J ;
Ng, IOL ;
Yamaoka, Y ;
Lauwers, GY ;
Vauthey, JN .
ARCHIVES OF SURGERY, 2005, 140 (05) :450-457
[25]   Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030 [J].
Petrick, Jessica L. ;
Kelly, Scott P. ;
Altekruse, Sean F. ;
McGlynn, Katherine A. ;
Rosenberg, Philip S. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15) :1787-+
[26]   External validation of a Cox prognostic model: principles and methods [J].
Royston, Patrick ;
Altman, Douglas G. .
BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13
[27]   Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective [J].
Sarasin, FP ;
Giostra, E ;
Mentha, G ;
Hadengue, A .
HEPATOLOGY, 1998, 28 (02) :436-442
[28]   Outcomes of resection of giant hepatocellular carcinoma in a tertiary institution: does size matter? [J].
Thng, Yongxian ;
Tan, Jarrod K. H. ;
Shridhar, Iyer G. ;
Chang, Stephen K. Y. ;
Madhavan, Krishnakumar ;
Kow, Alfred W. C. .
HPB, 2015, 17 (11) :988-993
[29]   Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study [J].
Vitale, Alessandro ;
Burra, Patrizia ;
Frigo, Anna Chiara ;
Trevisani, Franco ;
Farinati, Fabio ;
Spolverato, Gaya ;
Volk, Michael ;
Giannini, Edoardo G. ;
Ciccarese, Francesca ;
Piscaglia, Fabio ;
Rapaccini, Gian Lodovico ;
Di Marco, Mariella ;
Caturelli, Eugenio ;
Zoli, Marco ;
Borzio, Franco ;
Cabibbo, Giuseppe ;
Felder, Martina ;
Gasbarrini, Antonio ;
Sacco, Rodolfo ;
Foschi, Francesco Giuseppe ;
Missale, Gabriele ;
Morisco, Filomena ;
Baroni, Gianluca Svegliati ;
Virdone, Roberto ;
Cillo, Umberto .
JOURNAL OF HEPATOLOGY, 2015, 62 (03) :617-624
[30]   Perioperative Factors Affecting Long-Term Outcomes of 473 Consecutive Patients Undergoing Hepatectomy for Hepatocellular Carcinoma [J].
Wang, Chih-Chi ;
Iyer, Shridhar G. ;
Low, Jee Keem ;
Lin, Chih-Yun ;
Wang, Shih-Ho ;
Lu, Sen-Nan ;
Chen, Chao-Long .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) :1832-1842